OCEANSIDE, N.Y., April 2, 2012 /PRNewswire via COMTEX/ -- Today, Ellman International, Inc. announced the promotion Frank D’Amelio to the position of Chief Executive Officer and member of the Board of Directors. Mr. D’Amelio was previously Chief Operating Officer, Executive Vice President of Ellman International. He replaces Rick Epstein, who is leaving to pursue other interests.
Ellman is a leading provider of radiofrequency (RF) generators and accessories for both surgical applications and aesthetic procedures such as the non-invasive skin tightening product line Pelleve®. Ellman is primarily owned by Baird Capital Partners from Chicago, IL.
“We are excited to be working with Frank and the entire leadership team on executing our growth plans for Ellman,” said Gordon Pan, Partner at Baird Capital Partners. “Frank has demonstrated, both over the course of his career and here at Ellman, the ability to lead a medical technology device company and attract and cultivate top performers at all levels of the organization. In addition, we appreciate all of the contributions from Rick Epstein over the last four years. Rick’s leadership helped position the company for its next stage of growth.”
“I’m pleased to be leading Ellman with such a strong history in RF technology and devices. We have some great plans for continuing to grow Ellman’s non-surgical aesthetic business and equally as important, advancing new RF surgical systems,” said Frank D’Amelio, CEO of Ellman International, Inc. He added, “I believe that there is a tremendous opportunity to continue to expand and enhance our Pelleve non-invasive skin tightening system. We are also hard at work building our RF surgical pipeline. I see a tremendous future for Ellman, its physician partners and our share holders.”
Rick Epstein will remain on Ellman’s Board of Directors and will assist the company in a new advisory role.
About Ellman International, Inc.
Ellman International is a manufacturer of energy based devices to perform medical, aesthetic, dental and veterinary procedures in the United States, Europe, Latin America and Asia. Ellman’s product portfolio enables medical professionals to perform surgical procedures that produce less tissue damage, scarring and pain than the competition. The company is a leader in the use of radiofrequency generators for surgical and non-invasive aesthetic procedures, including Pelleve, a patented, painless procedure for skin tightening. Pelleve precisely delivers energy to the dermal tissue using advanced radiofrequency technology to induce collagen contraction without damaging the epidermis. The result is skin tightening and contouring with a noticeable improvement in skin quality and texture. For more information, visit www.ellman.com , www.pelleve.com and www.ellumine.com .
About Baird Capital PartnersBaird Capital Partners, the U.S.-based buyout fund of Baird Private Equity, invests in lower middle-market companies in the business services, manufactured products and healthcare sectors. Established in 1989, Baird Capital Partners leverages its deep sector knowledge, experienced investment team and extensive operating resources to drive value in its portfolio companies. Baird Capital Partners is supported by operating resources in China and India focused on facilitating and executing Asia sourcing, manufacturing and distribution strategies for Baird Capital Partners’ portfolio companies. Baird Private Equity is the global private equity group of Robert W. Baird & Co. (Baird). For more information, please visit bairdcapitalpartners.com.
SOURCE Ellman International, Inc.
